Skip to main content
Autonomous System

AS22641

Novo Nordisk Pharmaceutical, Inc.

Announced IPs
4,096
CIDR prefixes
3
ASN
AS22641

Reputation · trust score

A transparent 0–100 signal. Every entity starts at a neutral baseline of 65; threat-intel blocklists, exposure, reverse-DNS, routing and allocation each adjust it up or down. Higher is more trustworthy.

65/100
Moderate
How this score is built

Experimental · trust-vectors model v1.2.0 — a transparent heuristic, not a definitive verdict. How it works →

Top CIDR ranges

BGP Announced Prefixes

Live BGP anomalies →

Prefixes AS22641 actually originates in BGP, observed across our RIPE RIS collectors. This live routing view can differ from the registry allocation above.

PrefixAnnouncement samplesLast seen
216.169.210.0/23 13,457 2026-08-01 19:31:16
216.169.208.0/21 11,277 2026-08-01 19:31:16
216.169.216.0/21 11,272 2026-08-01 19:31:16
216.169.223.0/24 3,900 2026-08-01 19:31:22
216.169.222.0/24 3,895 2026-08-01 19:31:22
216.169.220.0/24 3,880 2026-08-01 19:31:22
216.169.221.0/24 3,877 2026-08-01 19:31:22

Frequently Asked Questions

What is AS22641?

AS22641 is an Autonomous System Number assigned to Novo Nordisk Pharmaceutical, Inc.. An ASN identifies a network that controls a specific set of IP addresses and determines how traffic is routed across the internet via BGP (Border Gateway Protocol).

How many IP addresses does AS22641 announce?

AS22641 announces 4.1K IPv4 addresses distributed across 3 routed CIDR prefixes. The network is registered in United States.

Who operates AS22641?

AS22641 is operated by Novo Nordisk Pharmaceutical, Inc.. The organization is based in United States. You can view all IP ranges and related ASNs on the organization page.

What country is AS22641 registered in?

AS22641 is registered in United States. This indicates where the network operator is headquartered, though the IP addresses it announces may serve users globally.

Last updated: 2026-08-01 19:40:31 UTC
Share